A Computer-Based System for Symptom Reporting in Patients With Cancer Undergoing Treatment
NCT ID: NCT03979846
Last Updated: 2025-05-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
20 participants
INTERVENTIONAL
2019-03-11
2019-05-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cancer & Chemotherapy Symptom Management Using an Automated Telephone Reporting System
NCT01979146
Cancer Symptom Monitoring Telephone System With Nurse Practitioner (NP) Follow up
NCT01973946
Online Nutrition Education to Decrease the Side Effects of Chemotherapy in Patients With Breast Cancer
NCT05874297
Automated Telephone Monitoring for Symptom Management
NCT00799084
Symptom Support During Chemotherapy: A Mixed Method Study in Adult Patients With Cancer
NCT02298972
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
I. To assess the usability and usefulness of a computer-based system for cancer patient symptom reporting.
SECONDARY OBJECTIVES:
I. To collect preliminary effectiveness data: quality of life outcomes with the Function Assessment of Cancer Therapy - General (FACT-G) and self-efficacy as measured by Chronic Disease Self-Efficacy Scale, Revised (CDSES-R).
OUTLINE: Participants are randomized to 1 of 2 arms.
ARM I: Participants receive usual care for 3 weeks, then use a computer-based symptom reporting system for 3 weeks. Caregivers may assist patients in the use of the computer based symptoms reporting system.
ARM II: Participants use a computer-based symptom reporting system for 3 weeks, then receive usual care for 3 weeks. Caregivers may assist patients in the use of the computer based symptoms reporting system.
After completing study intervention, participants are followed up for 30 days.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Arm I (usual care, computer-based symptom reporting)
Participants receive usual care for 3 weeks, then use a computer based symptom reporting system for 3 weeks. Caregivers may assist patients in the use of the computer based symptoms reporting system.
Best Practice
Receive usual care
Computer Application
Use computer-based symptom reporting system
Questionnaire Administration
Ancillary studies
Quality-of-Life Assessment
Ancillary studies
Arm II (computer-based symptom reporting, usual care)
Participants use a computer based symptom reporting system for 3 weeks, then receive usual care for 3 weeks. Caregivers may assist patients in the use of the computer based symptoms reporting system.
Best Practice
Receive usual care
Computer Application
Use computer-based symptom reporting system
Questionnaire Administration
Ancillary studies
Quality-of-Life Assessment
Ancillary studies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Best Practice
Receive usual care
Computer Application
Use computer-based symptom reporting system
Questionnaire Administration
Ancillary studies
Quality-of-Life Assessment
Ancillary studies
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* PATIENT: No clinical evidence of cognitive or psychological impairment.
* PATIENT: Home internet access on computer or phone.
Exclusion Criteria
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Thomas Jefferson University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ana Maria Lopez, MD
Role: PRINCIPAL_INVESTIGATOR
Sidney Kimmel Cancer Center at Thomas Jefferson University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Kennedy Health Systems- Cancer Center
Sewell, New Jersey, United States
Thomas Jefferson University Hopsital
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JT 13449
Identifier Type: OTHER
Identifier Source: secondary_id
19F.163
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.